skip to main content

Malaria semi-immunity — DTM&H MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMalariaMalaria semi-immunityDTM&H

A 55-year-old man who emigrated from Ghana 20 years ago presents with fever. He has had no malaria-endemic exposure since emigrating. Blood film shows P. falciparum at 0.3% with no severe features. What best explains his relatively low parasitaemia?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BResidual semi-immunity from childhood exposure that wanes slowly

The correct answer is B, residual semi-immunity from childhood exposure that wanes slowly. Individuals raised in holoendemic or hyperendemic malaria regions acquire partial protective immunity (premunition) through repeated childhood infections, which controls parasite multiplication and blunts peak parasitaemia without preventing infection outright. This semi-immunity declines gradually over years of non-exposure but is not lost immediately, explaining why long-term UK residents originally from endemic West Africa (such as Ghana) who present with imported falciparum malaria often have low parasite counts and few severe features compared with non-immune travellers. This is a well-recognised pattern in UK imported malaria practice and is a key reason visiting-friends-and-relatives (VFR) travellers, despite this partial protection, still require full chemoprophylaxis, as immunity is neither complete nor permanent. Why the other options are wrong: E. Sickle cell trait providing complete immunity: sickle trait gives only partial protection against severe falciparum disease via reduced parasite growth in HbAS red cells, it does not confer complete immunity and is not universal in this population. C. Acquired genetic resistance through epigenetic modification: there is no established clinical mechanism of epigenetically acquired malaria resistance used to explain reduced parasitaemia in returning migrants; this is not a recognised concept in UK malaria guidance. A. Cross-immunity from other Plasmodium species exposure: heterologous species cross-protection is minimal and not a recognised clinical explanation for reduced P. falciparum parasitaemia in semi-immune individuals. D. Natural immunity conferred by Duffy-negative blood group: Duffy negativity blocks P. vivax invasion via the Duffy antigen receptor, it has no protective effect against P. falciparum, which uses different invasion pathways. Key point: Semi-immunity acquired through childhood exposure to malaria wanes slowly but persists for years after leaving an endemic area, explaining lower parasitaemia and milder presentations in long-term migrants who develop imported falciparum malaria.

Reference: Public Health England Advisory Committee on Malaria Prevention (ACMP), UK malaria treatment guidelines 2016, Journal of Infection 2016; 72(6):635-649 (https://www.journalofinfection.com/article/S0163-4453(16)00047-5/fulltext)